At which type of companies do we have pharmaceutical jobs? And where?
Brunel works with Top Pharmaceutical clients worldwide. There is a vast variety of careers available within the pharmaceutical industry that Brunel supports from laboratory-based research and development, clinical trials, regulatory affairs, manufacturing, engineering, quality assurance, quality control, validation all the way through to marketing, sales and distribution.
Our portfolio of clients have a global presence with a strong reputation as industry leaders. Whether it be in animal health, biotechnology, pharmaceuticals or food, we have supported innovative companies in rapid-growth with mergers, acquisitions, and divestitures in finance, corporate, regulatory & development.
And where? Mostly in Canada (Calgary, Montreal and Toronto), United States and countries like Belgium, Germany and Russia.
Career outlook in pharmaceuticals
The pharmaceutical industry works to improve many people's lives by researching, developing, making and marketing medicines. This industry is home to a varied range of incredibly rewarding jobs.
This is a growing industry, and the number of jobs in the pharmaceutical industry is expected to continue rise.
As the pharmaceutical industry is so large, it is able to take on and train up individuals with a variety of education levels. From training within an internship to funding research for those with PhDs or equivalent, the pharmaceutical industry offers something for everyone.
Employees who work for pharmaceutical companies very often receive training and gain experience with new processes and technologies. This in itself is another reason you should consider working in the pharmaceutical industry.
Problems you'll help solve in pharmaceuticals
Drug discoveries today and in the future are realizing the vision of effectively treating “the right patient, at the right time, with the right medicine, at the right dose.”
This requires marrying chemistry and biology and using deeper understanding of the biological pathways of disease to identify better targets and designing molecules that more precisely alter those targets.
This approach has led to improved R&D productivity and efficiency, increasing the success of related clinical programs and reducing time to market for new medicines. It is this innovative work that will enable the industry to continue to fulfill our purpose of delivering lifesaving medicines to those who need them most.